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Mingxin Zhang*, Hanzhong Li, Yushi Zhang, Beijing, China, People's Republic of INTRODUCTION AND OBJECTIVES: Circulating tumor cells (CTCs) have emerged as promising tools for noninvasive cancer detection and prognosis. Most conventional approaches for capturing CTCs use an EpCAM-based enrichment strategy, which does not work well in cancers that show low or no expression of EpCAM, such as renal cell carcinoma (RCC). Karyotyping and phenotyping of circulating tumor cells (CTCs) in therapeutic cancer patients is of particular clinical significance in terms of both identifying CTC subtypes and understanding CTC evolution.
METHODS: The integrated subtraction enrichment (SET) and immunostaining-fluorescence in situ hybridization (iFISH) platform was applied to detect and characterize CTCs in patients with renal cell carcinoma (RCC). Status of vimentin expressing and aneuploidy of chromosome 8 in CTCs enriched from the patients was examined by SET-iFISH following VEGF-targeted therapy. CellSearch system was applied as a reference control.
RESULTS: Non-hematopoietic CTCs with heteroploid chromosome 8 were detected in 82% of RCC patients. Characterization of CTCs performed by vimentin-iFISH was strong positive in 50% of renal 
INTRODUCTION AND OBJECTIVES:
Proteome analysis has become one of the major approaches for the investigation of biomarkers predicting the prognosis of various types of malignant tumor, while metabolome analysis has recently been introduced in this field as the novel promising approach. Despite being widely spread for the screening of small biomolecules, conventional mass spectrometry (MS) analysis using tissue lysate cannot clearly distinguish between the cancerous and non-cancerous tissues; thus, there is a risk for obtaining false positive candidates. In this study, we applied desorption electrospray ionization imaging mass spectrometry (DESI-IMS), a novel molecular anatomy technique, to analyze a broad range of lipids in specimens from patients with clear cell renal cell carcinoma (CCRCC) to identify biomarkers that can predict the prognosis in these patients.
METHODS: Paired samples of the cancerous and normal renal cortex tissues were obtained from a total of 31 patients with CCRCC undergoing surgical resection. The DESI-IMS analyses of thinly sectioned samples were performed in negative ion mode with Xevo G2-XS (Waters, US). We picked up the ions showing 1.5 times higher signal intensity on the cancerous tissue compared with the normal tissue using High Definition Imaging software, and identified the molecules with LIPID MAPS database. We also analyzed the impact of candidate molecules on the overall survival (OS) in these 31 CCRCC patients.
RESULTS: The ions of m/z 187.10 (azelaic acid), m/z 279.23 (linoleic acid), m/z 281.25 (oleic acid), m/z 329.25 (docosapentaenoic acid), m/z 389.24 (not assigned), m/z 391.26 (not assigned), m/z 773.53 (PG (36:2)) were identified as the candidate biomarkers. Of these biomarkers, the low signal intensity of oleic acid as well as the high signal intensity of m/z 391.26 appeared to be significantly associated with the OS in the 31 patients with CCRCC.
CONCLUSIONS: In this study, we first identified seven lipid molecules specifically elevated on the cancerous tissue of CCRCC, and found the significant impacts of the signal intensities of oleic acid and m/ z 391.26 on the prognosis of CCRCC patients undergoing surgical resection. Although future prospective study with a larger sample size will be required, these findings provide new insights for early diagnosis and prognostic prediction in patients with CCRCC.
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